Related Experiment Video

Updated: Apr 7, 2026

Direct Reprogramming of Mouse Fibroblasts into Melanocytes
09:38

Direct Reprogramming of Mouse Fibroblasts into Melanocytes

Published on: August 27, 2021

2.6K

Recent Advances in Vitiligo Treatment

Ye Qiu1, Xiangxi Su1, Jingru Chen1

  • 1Department of Dermatology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, People's Republic of China.

Immunotargets and Therapy
|April 6, 2026
PubMed
Abstract

Insights

Recent vitiligo treatment advances focus on precision immune modulation. Janus kinase (JAK) inhibitors are now first-line, with novel biologics and combined therapies significantly improving repigmentation.

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Background:

  • Vitiligo is a chronic autoimmune condition characterized by depigmentation.
  • Current treatments aim to restore melanocytes and improve cosmetic outcomes.
  • Advances in understanding the immune pathogenesis of vitiligo drive therapeutic innovation.

Purpose of the Study:

  • To systematically review breakthrough vitiligo treatment advances from 2020 to 2025.
  • To provide evidence-based insights for clinical practice.
  • To highlight novel therapeutic strategies and their efficacy.

Main Methods:

  • Literature search of ClinicalTrials.gov and PubMed (2020-2025).
  • Inclusion of randomized controlled trials (RCTs), Phase II+ clinical trials, and translational research.
  • Systematic analysis of treatment outcomes and mechanisms of action.

Main Results:

  • Janus kinase (JAK) inhibitors demonstrate significant repigmentation by targeting the IFN-γ/JAK-STAT pathway.
  • Novel agents like IL-15 inhibitors selectively eliminate pathogenic T cells.
  • Combination therapies (e.g., 308 nm excimer laser with JAK inhibitors or platelet-rich plasma) show enhanced efficacy in acral vitiligo.
  • Vitamin D adjunct therapy, ReCell technology with narrowband UVB (NB-UVB), and miniature punch grafting offer additional treatment options.
  • Repurposed drugs and antioxidants expand the therapeutic arsenal.

Conclusions:

  • Vitiligo treatment has entered an era of precision immune modulation.
  • JAK inhibitors are established as first-line therapy, with novel biologics showing promise.
  • Combined phototherapy and cellular therapies enhance repigmentation efficiency.
  • Drug repurposing contributes to a richer therapeutic landscape.
Keywords:
IL-15 inhibitorsJAK inhibitorscombined phototherapytargeted therapyvitiligo

More Related Videos

Studying Chronic Exposure of Mice to Ultraviolet B Radiation03:20

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Published on: August 19, 2025

2.2K
Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

1.8K

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
4.2K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.6K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.4K
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
58
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K